mibefradil has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cifkova, R; Höglund, C; Lindberg, E; Mimran, A; Tenczer, J; Watt, A; Wilkins, MR | 1 |
| Claas, R; Cleutjens, JP; Daemen, MJ; Sandmann, S; Unger, T | 1 |
1 trial(s) available for mibefradil and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Antihypertensive Agents; Atenolol; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mibefradil; Tetrahydronaphthalenes | 1998 |
1 other study(ies) available for mibefradil and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mibefradil; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling; Verapamil | 2001 |